retatrutide obesity treatment 🧬 is being called the next generation of weight-loss medication, but it's not a shortcut, and it's definitely not for everyone. . ➡️ Unlike standard GLP-1 medications, retatrutide targets three hormone 💉 Retatrutide — The Future

In one experimental study, the estrogen antagonist was administered centrally with GLP-1 receptor agonist exendine 4 to fasting male and female rats, and different sensitivities to the food reward were noted between female and male rats

These include a history of pancreatitis, severe gastrointestinal conditions such as gastroparesis, gallbladder disease, and reduced kidney function, where dehydration from vomiting or diarrhea is the main concern

These approaches may not offer the rapid results of a GLP-1, but they lay a powerful foundation for long-term health and vitality

Phase 3 Trial Completion (2026) Before Eli Lilly can ask for approval, it needs to finish its main trials

If the dessert is worth it to you, have it

Its also pretty even between lunch and dinner